Replies to post #71561 on Biotech Values

[ghmm]

Sorry don't follow them.

Contrary to appearance I'm not trying to get the last update to the calendar (I'm just still in 2008 mode and 2009 is next year so got the year wrong for Oral Remodulin) :-)

[iwfal]

it's clear that atacicept's trials need to be removed (or moved) from the ZGEN listing since it was fully out-licensed to Merck Serono last fall.

? I would suggest that any trial that stands to influence a company's revenue by 100's of millions of dollars is pertinent to that company. ?